Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
GYRE
$6.92
-2.47%
GYRE
· Gyre Therapeutics, Inc.
$6.92
-0.18 (-2.47%)
At close · Oct 29
Return incl. dividend (before tax)
Market Cap
$790.60M
Shares
111.51M
Volume · Oct 29
78.64K
Avg daily vol (3M)
120.21K
All webcasts
Earnings call · FY2021 Q3
Gyre Therapeutics, Inc. (GYRE) Q3 2021 Earnings Call
Revenue
$2.30M
+157.4% YoY
Diluted EPS
-$12.00
Net income
-$25.24M
Forward guidance
3 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 12, 2021.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Costs related to one-time severance costs and related expenses
fourth quarter of 2021
|
at least $400,000 | — | |
|
Costs related to one-time severance costs and related expenses
first quarter of 2022
|
at least $200,000 | — | |
| Reduction in annual expenditures | 40% | — |
SEC filing · Item 2.02
8-K earnings release
Filed Nov 12, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 12, 2021 · complete as-filed document